2
Jun
2026

Rottendorf Pharma GmbH

Exhibitor at CPHI Americas 2026 stand 844
About Us

Rottendorf Pharma is a leading contract development and manufacturing organization (CDMO) with more than 95 years of experience in the development and manufacturing of formulations and analytical methods and packaging solutions for oral solid dosage forms for the global pharmaceutical industry. 
At two sites in Ennigerloh (Münsterland/ Germany), Rottendorf Pharma has first-class production facilities and technologies. 

Rottendorf Pharma's vision: “We strive to be the high performance end-to-end CDMO for sophisticated solids.”

  • Country/Region:
    Germany
  • Founded:
    1928
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    1000 - 4999
Company types
CMO/CDMO
Primary activities
Contract Manufacturer
Contact info
Event information
CPHI Americas 2026
  • 2 Jun 2026 - 4 June 2026
  • Pennsylvania Convention Center, Philadelphia
  • Visit us at stand 844

Products Featured at CPHI Americas 2026

  • Analytics

    Product Analytics

    Comprehensive analytical services from method development and transfer to routine testing of raw materials, excipients and finished products in a GMP/FDA-certified laboratory, leveraging over 180 experts and advanced techniques (HPLC, GC, dissolution, Karl Fischer, ICP, TLC, etc.) to ensure regulatory comp...
  • Blending

    Product Blending

    Robust mixing of APIs and excipients using high-shear blenders (Diosna P600, VAC 10+60) and free-fall blenders (Bohle PM-series) in both development (0.5–150 kg) and commercial manufacturing (2–750 kg) to achieve uniform blend homogeneity.
  • Blister Packaging

    Product Blister Packaging

    High-speed blister packaging on 13 fully automated lines (Uhlmann BEC 300/500, IMA Giant), handling PVC/PVDC, Alu-Alu, ACLAR® and PP foils with serialization and aggregation capabilities in a GMP certified cleanroom environment.
  • Bottle packaging

    Product Bottle packaging

    Automated bottle filling on three Uhlmann IBC 120/150 lines and one powder-filling line (Optima), including counting, induction sealing, torque-controlled capping and 100 % in-line inspection, all under GMP compliance.
  • Clinical trial manufacturing

    Product Clinical trial manufacturing

    GMP-compliant production of Phase I–III clinical samples (0.5–150 kg) in an FDA-approved pilot plant, with dedicated project teams for formulation, process upscaling and analytical method support.